Beasley Allen in Pharmaceutical News

Articles 291 to 300 of 323 in the Pharmaceutical section.

Vioxx shockwaves rock Merck

Merck & Co.'s Pandora's box has been opened wide, affecting much more than just the 20 million users of Vioxx.

Merck Faces Slew of Vioxx Suits

Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects - lawsuits that threaten to further damage the company's finances and reputation.

Vioxx Battles Could Cost Merck up to $18 Billion

Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck must now contend with hundreds of lawsuits over the drug’s side effects-lawsuits that threaten to further damage the company’s finances and reputation.

Lawyers Organizing for Mass Suits Over Vioxx

Hundreds of plaintiffs' lawyers who claim that people were injured or killed by the

Liablity could Reach $17.6B

Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects.

Vioxx battles could cost Merck up to $18B

Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck must now contend with hundreds of lawsuits over the drug's side effects.

Lawyers Organizing for Mass Lawsuits over Vioxx

Hundreds of plaintiffs' lawyers who claim that people were injured or killed by the painkiller Vioxx plan to meet next week to lay the groundwork for a nationwide legal assault against the drug's maker, Merck.

Merck Faces Slew Of Vioxx Lawsuits

Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects.

Merck Faces Huge Fallout Over Vioxx Suits

Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects - lawsuits that threaten to further damage the company's finances and reputation. Companies

News that maker hid Vioxx data sinks stock 10 percent

Shares of Merck & Co. plunged more than 10 percent yesterday after a news report said documents showed the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx causes heart problems.